advertisement
111974 Clinical efficacy of sclerotonyxis for acute angle-closure glaucoma with persistent high intraocular pressure
Zhang YY; Xu BB; Hu ZX; Zhang LG
European review for medical and pharmacological sciences 2023; 27: 7492-7499 (IGR: 24-3)
110088 Clinical efficacy of sclerotonyxis for acute angle-closure glaucoma with persistent high intraocular pressure
Zhang YY; Xu BB; Hu ZX; Zhang LG
European review for medical and pharmacological sciences 2023; 27: 7492-7499 (IGR: 24-1/2)
108308 Association of diabetes, fasting glucose, and the risk of glaucoma: a systematic review and meta-analysis
AlDarrab A; Al Jarallah OJ; Al Balawi HB
European review for medical and pharmacological sciences 2023; 27: 2419-2427 (IGR: 23-4)
104678 Literature review on the cross-link between ocular and renal disease: renin angiotensin aldosterone system is a main actor
Lai S; Perrotta AM; Bagordo D; Mazzaferro S; Menè P; Errigo F; Tinti F; Rotondi S; Molfino A; Simeoni M; Mitterhofer AP; Cianci R
European review for medical and pharmacological sciences 2022; 26: 4774-4788 (IGR: 23-2)
100862 Comparison of two sedation protocols on intraocular pressure and hemodynamic responses during colonoscopy
Bayraktaroglu M; Kurtay A; Horasanli E
European review for medical and pharmacological sciences 2022; 26: 4295-4302 (IGR: 23-1)
91727 A clinical characteristics and genetic analysis of a case of Rubinstein-Taybi syndrome with glaucoma
Huang FR; Zhang AM; Xu J; Huang L
European review for medical and pharmacological sciences 2021; 25: 1447-1454 (IGR: 21-4)
90580 Neuroprotective role of phosphoserine in primary open-angle glaucoma patients
Scalinci SZ; Lugaresi M; Scorolli L; Ralli M; Greco A; Pantaleone V; Taurone S; Franzone F
European review for medical and pharmacological sciences 2020; 24: 9780-9786 (IGR: 21-3)
82186 HLA-DPA1 gene polymorphism in primary glaucoma
Li JH; Shao JF; Sui ZG; Qin YX
European review for medical and pharmacological sciences 2019; 23: 24-30 (IGR: 20-4)
81031 Long non-coding RNA ANRIL down-regulates microRNA-7 to protect human trabecular meshwork cells in an experimental model for glaucoma
Zhao J
European review for medical and pharmacological sciences 2019; 23: 3173-3182 (IGR: 20-3)
81421 Correlations of TIMP2 and TIMP3 gene polymorphisms with primary open-angle glaucoma
Ji ML; Jia J
European review for medical and pharmacological sciences 2019; 23: 5542-5547 (IGR: 20-3)
81031 Long non-coding RNA ANRIL down-regulates microRNA-7 to protect human trabecular meshwork cells in an experimental model for glaucoma
Sun H; Zhang JM; Wang M; Du XJ; Zhang JL
European review for medical and pharmacological sciences 2019; 23: 3173-3182 (IGR: 20-3)
77121 MEG3 is involved in the development of glaucoma through promoting the autophagy of retinal ganglion cells
Sun W
European review for medical and pharmacological sciences 2018; 22: 2534-2540 (IGR: 19-3)
77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Wang XC
European review for medical and pharmacological sciences 2018; 22: 2934-2940 (IGR: 19-3)
77121 MEG3 is involved in the development of glaucoma through promoting the autophagy of retinal ganglion cells
Li YN
European review for medical and pharmacological sciences 2018; 22: 2534-2540 (IGR: 19-3)
77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Wang T
European review for medical and pharmacological sciences 2018; 22: 2934-2940 (IGR: 19-3)
77121 MEG3 is involved in the development of glaucoma through promoting the autophagy of retinal ganglion cells
Ye JF
European review for medical and pharmacological sciences 2018; 22: 2534-2540 (IGR: 19-3)
77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Zhang Y
European review for medical and pharmacological sciences 2018; 22: 2934-2940 (IGR: 19-3)
77121 MEG3 is involved in the development of glaucoma through promoting the autophagy of retinal ganglion cells
Guan YQ
European review for medical and pharmacological sciences 2018; 22: 2534-2540 (IGR: 19-3)
77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Wang LL; Zhao RY
European review for medical and pharmacological sciences 2018; 22: 2934-2940 (IGR: 19-3)
77121 MEG3 is involved in the development of glaucoma through promoting the autophagy of retinal ganglion cells
Li SJ
European review for medical and pharmacological sciences 2018; 22: 2534-2540 (IGR: 19-3)
77257 Tacrolimus inhibits proliferation and induces apoptosis by decreasing survivin in scar fibroblasts after glaucoma surgery
Tan W
European review for medical and pharmacological sciences 2018; 22: 2934-2940 (IGR: 19-3)
74586 Correlation between presence of primary iris- and cilliary body cysts and intraocular pressure
Xue KC; Hu DD; Zhao L; Li N; Shen HY
European review for medical and pharmacological sciences 2017; 21: 3985-3989 (IGR: 19-1)
55616 Exploring the potential mechanism and screening small molecule drugs for glaucoma by using bioinformatics approach
Liao Q; Sun XY; Guo H; Li C
European review for medical and pharmacological sciences 2014; 18: 132-140 (IGR: 15-4)
54049 Botulinum toxin treatment in glaucomatous patients: a pilot study
Librando A; Russo V; Tarallo M; Cruciani F; Carlesimo SC; Nebbioso M
European review for medical and pharmacological sciences 2013; 17: 1835-1838 (IGR: 15-2)
52536 Treatment of glaucomatous patients by means of food supplement to reduce the ocular discomfort: a double blind randomized trial
Nebbioso M; Rusciano D; Pucci B; Zicari AM; Grenga R; Pescocolido N
European review for medical and pharmacological sciences 2013; 17: 1117-1122 (IGR: 15-1)